Immix Biopharma (IMMX) announced that it has received a strategic investment from Goose Capital and former Tanox, Inc. CEO Nancy Chang, Goose founding member. At Tanox, Chang and her team invented and developed FDA-approved Xolair for severe asthma, Trogarzo for HIV, and Ebglyss for dermatitis, collectively generating drug sales exceeding $5B dollars so far.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IMMX: